The National Institute of Arthritis and Musculoskeletal and Skin Diseases is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services.

During the past decade, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" are "Rheumatoid Arthritis" (6 trials), "Arthritis, Rheumatoid" (4 trials), "Dermatomyositis" (3 trials), "Synovitis" (3 trials) and "Systemic Lupus Erythematosus" (3 trials). Many other conditions were trialed in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" in a lesser frequency.

Most popular intervention types in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" are "Drug" (14 trials). Other intervention types were less common.

The name of intervention was led by "Infliximab" (2 trials), "15-O labeled water" (1 trials), "2-deoxy-2 [F-18] fluoro-2-d-glucose" (1 trials), "BG9588" (1 trials) and "Canakinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".